IL106751A0 - Pharmaceutical compositions for the treatment of reversible obstructive airways diseases - Google Patents
Pharmaceutical compositions for the treatment of reversible obstructive airways diseasesInfo
- Publication number
- IL106751A0 IL106751A0 IL106751A IL10675193A IL106751A0 IL 106751 A0 IL106751 A0 IL 106751A0 IL 106751 A IL106751 A IL 106751A IL 10675193 A IL10675193 A IL 10675193A IL 106751 A0 IL106751 A0 IL 106751A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- pharmaceutical compositions
- obstructive airways
- airways diseases
- reversible obstructive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929218027A GB9218027D0 (en) | 1992-08-25 | 1992-08-25 | Novel method of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL106751A0 true IL106751A0 (en) | 1993-12-08 |
Family
ID=10720906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL106751A IL106751A0 (en) | 1992-08-25 | 1993-08-20 | Pharmaceutical compositions for the treatment of reversible obstructive airways diseases |
Country Status (6)
| Country | Link |
|---|---|
| AU (1) | AU4967193A (xx) |
| GB (1) | GB9218027D0 (xx) |
| IL (1) | IL106751A0 (xx) |
| MX (1) | MX9305152A (xx) |
| WO (1) | WO1994004148A1 (xx) |
| ZA (1) | ZA936137B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP223198A0 (en) * | 1998-03-06 | 1998-04-02 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
| ES2343124T3 (es) | 1999-10-29 | 2010-07-23 | Novartis Ag | Composiciones de polvo seco con dispersabilidad mejorada. |
| US6878751B1 (en) * | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
| AR035411A1 (es) * | 2000-12-29 | 2004-05-26 | Fujisawa Pharmaceutical Co | Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto |
| CA2554045A1 (en) * | 2004-01-20 | 2005-07-28 | Astellas Pharma Inc. | Method for treating erectile dysfunction |
| KR20190075120A (ko) | 2016-11-10 | 2019-06-28 | 노파르티스 아게 | Bmp 강화제 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0323042A1 (en) * | 1987-12-09 | 1989-07-05 | FISONS plc | Process to macrocyclic compounds |
| IE64214B1 (en) * | 1989-06-06 | 1995-07-26 | Fujisawa Pharmaceutical Co | Macrolides for the treatment of reversible obstructive airways diseases |
| GR1001225B (el) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους. |
| IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
-
1992
- 1992-08-25 GB GB929218027A patent/GB9218027D0/en active Pending
-
1993
- 1993-08-20 WO PCT/GB1993/001769 patent/WO1994004148A1/en active Application Filing
- 1993-08-20 ZA ZA936137A patent/ZA936137B/xx unknown
- 1993-08-20 IL IL106751A patent/IL106751A0/xx unknown
- 1993-08-20 AU AU49671/93A patent/AU4967193A/en not_active Abandoned
- 1993-08-25 MX MX9305152A patent/MX9305152A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994004148A1 (en) | 1994-03-03 |
| ZA936137B (en) | 1994-02-21 |
| AU4967193A (en) | 1994-03-15 |
| MX9305152A (es) | 1994-05-31 |
| GB9218027D0 (en) | 1992-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0707446A4 (en) | PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR TREATING NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOM COMPLEXES | |
| IL90910A0 (en) | Pharmaceutical composition for the prevention of sexually transmittable diseases | |
| IL113263A0 (en) | Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases | |
| HU9502520D0 (en) | Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives | |
| ZA983602B (en) | Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination | |
| IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
| IL76561A (en) | Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases | |
| AU6858996A (en) | Pharmaceutical compositions for the treatment of infectious diseases | |
| HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
| HU9402709D0 (en) | Pentofixillin for producing pharmaceutical compositions for treating lung diseases of granuloma and fibrozis | |
| IL101245A0 (en) | Pharmaceutical compositions for the treatment of prostatic cancer | |
| IL106751A0 (en) | Pharmaceutical compositions for the treatment of reversible obstructive airways diseases | |
| AU3684395A (en) | Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases | |
| HUP9900309A3 (en) | Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases | |
| IL104132A0 (en) | Compositions for the treatment of mammalian diseases | |
| HU9302906D0 (en) | Pharmaceutical product for disease of respiratory organs | |
| IL105061A (en) | Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof | |
| ZA943342B (en) | The use of compositions for combating tumour diseases | |
| IL109235A0 (en) | Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases | |
| HUP9801925A3 (en) | Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons | |
| IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
| IL105690A0 (en) | Pharmaceutical compositions for the treatment of arrhythmia | |
| HUP0000569A3 (en) | Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
| IL99236A0 (en) | Pharmaceutical composition for the topical treatment of psoriasis | |
| HUP9702408A3 (en) | Use of 5-phenyloxazolidin-2-one derivatives for the preparation of pharmaceutical compositions treating diseases requiring tumour necrosis factor (tnf) inhibition |